GeneDx stock holds steady despite fraud allegations
GeneDx (NASDAQ:WGS) shares maintained their ground following a reiteration of a Hold rating and a $75.00 price target by Jefferies analysts. According to InvestingPro data, analyst targets for the ...
BTIG maintains GeneDx stock Buy rating, $95 target amid fraud claim
BTIG analysts stood firm on their positive stance towards GeneDx (NASDAQ:WGS), reiterating a Buy rating and a $95.00 price target for the company's stock. With analyst targets ranging from $70 to $118 ...
GeneDx selloff after short report ‘appears overdone,’ says Wells Fargo
Wells Fargo notes that shares of GeneDx (WGS) are trading lower after a short report was published this morning by Grizzly Research, adding ...
BTIG says GeneDx short report creates buying opportunity
BTIG analyst Mark Massaro notes that earlier today, a short report was published on GeneDx (WGS), which alleges wholesale reimbursement fraud ...
GeneDx targeted in short report by Grizzly Research
In 2022, before changing its name from Sema4 to GeneDx, the company had a dispute with UnitedHealthcare, which resulted in a ...
American Association of Individual Investors3d
Which Is a Better Investment, The Ensign Group, Inc. or GeneDx Holdings Corp. Stock?
Learn more about whether The Ensign Group, Inc. or GeneDx Holdings Corp. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
American Association of Individual Investors3d
Which Is a Better Investment, Clover Health Investments, Corp. or GeneDx Holdings Corp. Stock?
Learn more about whether Clover Health Investments, Corp. or GeneDx Holdings Corp. is a better investment based on AAII's A+ ...
PFG Investments LLC Acquires Shares of 3,274 GeneDx Holdings Corp. (NASDAQ:WGS)
PFG Investments LLC bought a new position in GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The firm bought 3,274 shares of ...